Literature DB >> 3779098

Lysis of human fibroblast colony-forming cells and endothelial cells by monoclonal antibody (6-19) and complement.

C N Abboud, R E Duerst, C N Frantz, D H Ryan, J L Liesveld, J K Brennan.   

Abstract

The murine IgG2a monoclonal antibody 6-19 binds to a wide variety of nonhematopoietic cells including human marrow-derived stromal cells but does not bind to marrow or peripheral blood cells. We studied the effects of this antibody and rabbit complement on marrow cells. Fibroblast colonies were eliminated from light density marrow cells by a single incubation with monoclonal antibody 6-19 and complement. The growth and composition of granulocytic and erythroid colonies were unaffected. Specific complement mediated cytotoxicity of the antibody was confirmed on passaged human fibroblasts derived from marrow (more than 99.6% of fibroblasts are killed by a single treatment). Similar results were obtained with human umbilical cord endothelial cells. In addition, such treatment abolished the initiation of Dexter culture stroma. Incubation of bone marrow cell suspensions with this antibody and complement will allow the study of stroma-free marrow cells in long-term liquid cultures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779098

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  A comparative study of magnetic-activated cell sorting, cytotoxicity and preplating for the purification of human myoblasts.

Authors:  Yoon Ghil Park; Jae Ho Moon; Jin Kim
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

3.  Stem cell isolation by a morphology-based selection method in postnatal mouse ovary.

Authors:  Soraya Parvari; Mehdi Abbasi; Niloufar Abbasi; Valliollah Gerayeli Malek; Fardin Amidi; Fereydoon Sargolzaei Aval; Mehryar Habibi Roudkenar; Fariburz Izadyar
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.